{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:19:09Z","timestamp":1788830349372,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11845-024-03789-0","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T10:02:42Z","timestamp":1727344962000},"page":"2681-2694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exosomal miR-502-5p suppresses the progression of gastric cancer by repressing angiogenesis through the Wnt\/\u03b2-catenin pathway"],"prefix":"10.1007","volume":"193","author":[{"given":"Yanwu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"key":"3789_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI et al (2020) Gastric cancer. Lancet 396:635\u2013648. https:\/\/doi.org\/10.1016\/S0140-6736(20)31288-5","journal-title":"Lancet"},{"key":"3789_CR2","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1017\/erm.2023.7","volume":"25","author":"MC Sell","year":"2023","unstructured":"Sell MC, Ramlogan-Steel CA, Steel JC, Dhungel BP (2023) MicroRNAs in cancer metastasis: biological and therapeutic implications. Expert Rev Mol Med 25:e14. https:\/\/doi.org\/10.1017\/erm.2023.7","journal-title":"Expert Rev Mol Med"},{"key":"3789_CR3","doi-asserted-by":"publisher","unstructured":"Mehterov N (2023) Role of microRNAs in cancer development and treatment. Int J Mol Sci 24:11058. https:\/\/doi.org\/10.3390\/ijms241311058","DOI":"10.3390\/ijms241311058"},{"key":"3789_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1470-2045(09)70343-2","volume":"11","author":"T Ueda","year":"2010","unstructured":"Ueda T, Volinia S, Okumura H and others (2010) Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11:136\u2013146. https:\/\/doi.org\/10.1016\/S1470-2045(09)70343-2","journal-title":"Lancet Oncol"},{"key":"3789_CR5","doi-asserted-by":"publisher","first-page":"8465","DOI":"10.1002\/jcp.27776","volume":"234","author":"R Mardani","year":"2019","unstructured":"Mardani R, Jafari Najaf Abadi MH, Motieian M and others (2019) MicroRNA in leukemia: tumor suppressors and oncogenes with prognostic potential. J Cell Physiol 234:8465\u20138486. https:\/\/doi.org\/10.1002\/jcp.27776","journal-title":"J Cell Physiol"},{"key":"3789_CR6","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1056\/NEJMp058190","volume":"353","author":"CZ Chen","year":"2005","unstructured":"Chen CZ (2005) MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353:1768\u20131771. https:\/\/doi.org\/10.1056\/NEJMp058190","journal-title":"N Engl J Med"},{"key":"3789_CR7","doi-asserted-by":"publisher","unstructured":"Velkova I, Pasino M, Khalid Z et al (2023) Modulation of ferroptosis by microRNAs in human cancer. J Pers Med 13:719. https:\/\/doi.org\/10.3390\/jpm13050719","DOI":"10.3390\/jpm13050719"},{"key":"3789_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13046-018-0995-9","volume":"38","author":"R Wang","year":"2019","unstructured":"Wang R, Sun Y, Yu W and others (2019) Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT. J Exp Clin Cancer Res 38:20. https:\/\/doi.org\/10.1186\/s13046-018-0995-9","journal-title":"J Exp Clin Cancer Res"},{"key":"3789_CR9","doi-asserted-by":"publisher","first-page":"100936","DOI":"10.1016\/j.drup.2023.100936","volume":"68","author":"X Qu","year":"2023","unstructured":"Qu X, Liu B, Wang L and others (2023) Loss of cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer. Drug Resist Updat 68:100936. https:\/\/doi.org\/10.1016\/j.drup.2023.100936","journal-title":"Drug Resist Updat"},{"key":"3789_CR10","doi-asserted-by":"publisher","first-page":"1158839","DOI":"10.3389\/fphys.2023.1158839","volume":"14","author":"C Jiang","year":"2023","unstructured":"Jiang C, Zhang J, Wang W and others (2023) Extracellular vesicles in gastric cancer: role of exosomal lncRNA and microRNA as diagnostic and therapeutic targets. Front Physiol 14:1158839. https:\/\/doi.org\/10.3389\/fphys.2023.1158839","journal-title":"Front Physiol"},{"key":"3789_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12935-020-01479-2","volume":"20","author":"W You","year":"2020","unstructured":"You W, Liu X, Yu Y and others (2020) miR-502-5p affects gastric cancer progression by targeting PD-L1. Cancer Cell Int 20:395. https:\/\/doi.org\/10.1186\/s12935-020-01479-2","journal-title":"Cancer Cell Int"},{"key":"3789_CR12","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1080\/21655979.2021.1946347","volume":"12","author":"L Zhan","year":"2021","unstructured":"Zhan L, Yang J, Liu Y et al (2021) MicroRNA miR-502-5p inhibits ovarian cancer genesis by downregulation of GINS complex subunit 2. Bioengineered 12:3336\u20133347. https:\/\/doi.org\/10.1080\/21655979.2021.1946347","journal-title":"Bioengineered"},{"key":"3789_CR13","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.3892\/or.2014.3105","volume":"31","author":"LL Sun","year":"2014","unstructured":"Sun LL, Wang J, Zhao ZJ and others (2014) Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2. Oncol Rep 31:2085\u20132092. https:\/\/doi.org\/10.3892\/or.2014.3105","journal-title":"Oncol Rep"},{"key":"3789_CR14","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/onc.2012.167","volume":"32","author":"H Zhai","year":"2013","unstructured":"Zhai H, Song B, Xu X et al (2013) Inhibition of autophagy and tumor growth in colon cancer by miR-502. Oncogene 32:1570\u20131579. https:\/\/doi.org\/10.1038\/onc.2012.167","journal-title":"Oncogene"},{"key":"3789_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13046-020-01769-7","volume":"39","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Song J, Tang B and others (2020) CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2\/STAT3 signaling pathway. J Exp Clin Cancer Res 39:259. https:\/\/doi.org\/10.1186\/s13046-020-01769-7","journal-title":"J Exp Clin Cancer Res"},{"key":"3789_CR16","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.3892\/ol.2020.11808","volume":"20","author":"X Peng","year":"2020","unstructured":"Peng X, Wu M, Liu W et al (2020) miR-502-5p inhibits the proliferation, migration and invasion of gastric cancer cells by targeting SP1. Oncol Lett 20:2757\u20132762. https:\/\/doi.org\/10.3892\/ol.2020.11808","journal-title":"Oncol Lett"},{"key":"3789_CR17","doi-asserted-by":"publisher","unstructured":"Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science 367:eaau6977. https:\/\/doi.org\/10.1126\/science.aau6977","DOI":"10.1126\/science.aau6977"},{"key":"3789_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12943-018-0897-7","volume":"17","author":"Z Sun","year":"2018","unstructured":"Sun Z, Shi K, Yang S and others (2018) Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer 17:147. https:\/\/doi.org\/10.1186\/s12943-018-0897-7","journal-title":"Mol Cancer"},{"key":"3789_CR19","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s10495-022-01738-9","volume":"27","author":"C Yu","year":"2022","unstructured":"Yu C, Xue B, Li J, Zhang Q (2022) Tumor cell-derived exosome RNF126 affects the immune microenvironment and promotes nasopharyngeal carcinoma progression by regulating PTEN ubiquitination. Apoptosis 27:590\u2013605. https:\/\/doi.org\/10.1007\/s10495-022-01738-9","journal-title":"Apoptosis"},{"key":"3789_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/carcin\/bgad013","volume":"44","author":"K Liu","year":"2023","unstructured":"Liu K, Dou R, Yang C and others (2023) Exosome-transmitted miR-29a induces colorectal cancer metastasis by destroying the vascular endothelial barrier. Carcinogenesis 44:356\u2013367. https:\/\/doi.org\/10.1093\/carcin\/bgad013","journal-title":"Carcinogenesis"},{"key":"3789_CR21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00428-017-2276-y","volume":"472","author":"L Bertero","year":"2018","unstructured":"Bertero L, Massa F, Metovic J and others (2018) Eighth edition of the UICC classification of malignant tumours: an overview of the changes in the pathological TNM classification criteria-what has changed and why? Virchows Arch 472:519\u2013531. https:\/\/doi.org\/10.1007\/s00428-017-2276-y","journal-title":"Virchows Arch"},{"key":"3789_CR22","doi-asserted-by":"publisher","first-page":"100274","DOI":"10.1016\/j.xpro.2020.100274","volume":"2","author":"B Ziman","year":"2021","unstructured":"Ziman B, Oviedo NJ (2021) Measuring protein levels in planarians using western blotting. STAR Protoc 2:100274. https:\/\/doi.org\/10.1016\/j.xpro.2020.100274","journal-title":"STAR Protoc"},{"key":"3789_CR23","doi-asserted-by":"publisher","first-page":"11150","DOI":"10.1038\/ncomms11150","volume":"7","author":"CL Au Yeung","year":"2016","unstructured":"Au Yeung CL, Co NN, Tsuruga T and others (2016) Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. Nat Commun 7:11150. https:\/\/doi.org\/10.1038\/ncomms11150","journal-title":"Nat Commun"},{"key":"3789_CR24","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstrom K, Bossios A et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654\u2013659. https:\/\/doi.org\/10.1038\/ncb1596","journal-title":"Nat Cell Biol"},{"key":"3789_CR25","doi-asserted-by":"publisher","unstructured":"Nienh\u00fcser H, Schmidt T (2017) Angiogenesis and anti-angiogenic therapy in gastric cancer. Int J Mol Sci 19:43. https:\/\/doi.org\/10.3390\/ijms19010043","DOI":"10.3390\/ijms19010043"},{"key":"3789_CR26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"ZL Liu","year":"2023","unstructured":"Liu ZL, Chen HH, Zheng LL et al (2023) Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther 8:198. https:\/\/doi.org\/10.1038\/s41392-023-01460-1","journal-title":"Signal Transduct Target Ther"},{"key":"3789_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12935-019-0799-9","volume":"19","author":"L Tang","year":"2019","unstructured":"Tang L, Wen JB, Wen P et al (2019) Long non-coding RNA LINC01314 represses cell migration, invasion, and angiogenesis in gastric cancer via the Wnt\/\u03b2-catenin signaling pathway by down-regulating KLK4. Cancer Cell Int 19:94. https:\/\/doi.org\/10.1186\/s12935-019-0799-9","journal-title":"Cancer Cell Int"},{"key":"3789_CR28","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1158\/0008-5472.Can-22-1695","volume":"82","author":"CL Hong","year":"2022","unstructured":"Hong CL, Yu IS, Pai CH and others (2022) CD248 regulates Wnt signaling in pericytes to promote angiogenesis and tumor growth in lung cancer. Cancer Res 82:3734\u20133750. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-1695","journal-title":"Cancer Res"},{"key":"3789_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12943-018-0874-1","volume":"17","author":"XZ Yang","year":"2018","unstructured":"Yang XZ, Cheng TT, He QJ and others (2018) LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt\/\u03b2-catenin pathway. Mol Cancer 17:126. https:\/\/doi.org\/10.1186\/s12943-018-0874-1","journal-title":"Mol Cancer"},{"key":"3789_CR30","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/gutjnl-2019-320368","volume":"70","author":"M Zhang","year":"2021","unstructured":"Zhang M, Hu S, Min M and others (2021) Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing. Gut 70:464\u2013475. https:\/\/doi.org\/10.1136\/gutjnl-2019-320368","journal-title":"Gut"},{"key":"3789_CR31","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.7150\/thno.34989","volume":"9","author":"Y Dong","year":"2019","unstructured":"Dong Y, Zhang Y, Kang W and others (2019) VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6. Theranostics 9:6517\u20136531. https:\/\/doi.org\/10.7150\/thno.34989","journal-title":"Theranostics"},{"key":"3789_CR32","doi-asserted-by":"publisher","unstructured":"Shishido A, Miyo M, Oishi K et al (2023) The relationship between LRP6 and Wnt\/\u03b2-catenin pathway in colorectal and esophageal cancer. Life (Basel) 13:615. https:\/\/doi.org\/10.3390\/life13030615","DOI":"10.3390\/life13030615"},{"key":"3789_CR33","doi-asserted-by":"publisher","first-page":"e36565","DOI":"10.1371\/journal.pone.0036565","volume":"7","author":"EK Tung","year":"2012","unstructured":"Tung EK, Wong BY, Yau TO, Ng IO (2012) Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasion. PLoS One 7:e36565. https:\/\/doi.org\/10.1371\/journal.pone.0036565","journal-title":"PLoS One"},{"key":"3789_CR34","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/s41388-022-02259-0","volume":"41","author":"Z Rong","year":"2022","unstructured":"Rong Z, Zhang L, Li Z and others (2022) SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt\/\u03b2-catenin signaling. Oncogene 41:2390\u20132403. https:\/\/doi.org\/10.1038\/s41388-022-02259-0","journal-title":"Oncogene"},{"key":"3789_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.canlet.2016.11.026","volume":"388","author":"B Garg","year":"2017","unstructured":"Garg B, Giri B, Majumder K et al (2017) Modulation of post-translational modifications in \u03b2-catenin and LRP6 inhibits Wnt signaling pathway in pancreatic cancer. Cancer Lett 388:64\u201372. https:\/\/doi.org\/10.1016\/j.canlet.2016.11.026","journal-title":"Cancer Lett"},{"key":"3789_CR36","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00018-019-03035-2","volume":"76","author":"H Kahroba","year":"2019","unstructured":"Kahroba H, Hejazi MS, Samadi N (2019) Exosomes: from carcinogenesis and metastasis to diagnosis and treatment of gastric cancer. Cell Mol Life Sci 76:1747\u20131758. https:\/\/doi.org\/10.1007\/s00018-019-03035-2","journal-title":"Cell Mol Life Sci"},{"key":"3789_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13045-022-01305-4","volume":"15","author":"MDA Paskeh","year":"2022","unstructured":"Paskeh MDA, Entezari M, Mirzaei S and others (2022) Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. J Hematol Oncol 15:83. https:\/\/doi.org\/10.1186\/s13045-022-01305-4","journal-title":"J Hematol Oncol"},{"key":"3789_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13046-019-1511-6","volume":"39","author":"S Wei","year":"2020","unstructured":"Wei S, Peng L, Yang J and others (2020) Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1\/caspase-3\/caspase-9 signaling pathway in gastric cancer. J Exp Clin Cancer Res 39:32. https:\/\/doi.org\/10.1186\/s13046-019-1511-6","journal-title":"J Exp Clin Cancer Res"},{"key":"3789_CR39","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.7150\/thno.53412","volume":"11","author":"B Chen","year":"2021","unstructured":"Chen B, Sang Y, Song X and others (2021) Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28. Theranostics 11:3932\u20133947. https:\/\/doi.org\/10.7150\/thno.53412","journal-title":"Theranostics"},{"key":"3789_CR40","doi-asserted-by":"publisher","unstructured":"Seyhan AA (2023) Circulating microRNAs as potential biomarkers in pancreatic cancer-advances and challenges. Int J Mol Sci 24:13340. https:\/\/doi.org\/10.3390\/ijms241713340","DOI":"10.3390\/ijms241713340"},{"key":"3789_CR41","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-021-01444-1","volume":"20","author":"J Li","year":"2021","unstructured":"Li J, Gao X, Zhang Z and others (2021) CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p\/KRAS and IGF2BP2\/Myc axes. Mol Cancer 20:138. https:\/\/doi.org\/10.1186\/s12943-021-01444-1","journal-title":"Mol Cancer"},{"key":"3789_CR42","doi-asserted-by":"publisher","first-page":"e12751","DOI":"10.1111\/cpr.12751","volume":"53","author":"Y Ying","year":"2020","unstructured":"Ying Y, Li J, Xie H and others (2020) CCND1, NOP14 and DNMT3B are involved in miR-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer. Cell Prolif 53:e12751. https:\/\/doi.org\/10.1111\/cpr.12751","journal-title":"Cell Prolif"},{"key":"3789_CR43","doi-asserted-by":"publisher","unstructured":"Raisch J, C\u00f4t\u00e9-Biron A, Rivard N (2019) A role for the WNT Co-receptor LRP6 in pathogenesis and therapy of epithelial cancers. Cancers (Basel) 11:1162. https:\/\/doi.org\/10.3390\/cancers11081162","DOI":"10.3390\/cancers11081162"},{"key":"3789_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10787-022-01115-7","volume":"31","author":"S Sadeghi","year":"2023","unstructured":"Sadeghi S, Tehrani FR, Tahmasebi S et al (2023) Exosome engineering in cell therapy and drug delivery. Inflammopharmacology 31:145\u2013169. https:\/\/doi.org\/10.1007\/s10787-022-01115-7","journal-title":"Inflammopharmacology"},{"key":"3789_CR45","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1111\/jocd.15008","volume":"21","author":"Y Kost","year":"2022","unstructured":"Kost Y, Muskat A, Mhaimeed N et al (2022) Exosome therapy in hair regeneration: a literature review of the evidence, challenges, and future opportunities. J Cosmet Dermatol 21:3226\u20133231. https:\/\/doi.org\/10.1111\/jocd.15008","journal-title":"J Cosmet Dermatol"},{"key":"3789_CR46","doi-asserted-by":"publisher","first-page":"eabp9435","DOI":"10.1126\/sciadv.abp9435","volume":"8","author":"T Wan","year":"2022","unstructured":"Wan T, Zhong J, Pan Q et al (2022) Exosome-mediated delivery of Cas9 ribonucleoprotein complexes for tissue-specific gene therapy of liver diseases. Sci Adv 8:eabp9435. https:\/\/doi.org\/10.1126\/sciadv.abp9435","journal-title":"Sci Adv"},{"key":"3789_CR47","doi-asserted-by":"publisher","first-page":"e21916","DOI":"10.1096\/fj.202100294RR","volume":"35","author":"B Li","year":"2021","unstructured":"Li B, Cao Y, Sun M, Feng H (2021) Expression, regulation, and function of exosome-derived miRNAs in cancer progression and therapy. Faseb J 35:e21916. https:\/\/doi.org\/10.1096\/fj.202100294RR","journal-title":"Faseb J"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03789-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-024-03789-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03789-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T07:26:25Z","timestamp":1734938785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-024-03789-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["3789"],"URL":"https:\/\/doi.org\/10.1007\/s11845-024-03789-0","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,26]]},"assertion":[{"value":"30 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all clinical participants, and the study protocol was approved by the ethics committee of the Second Xiangya Hospital of Central South University (approval no. (2022)033; Changsha, China). All mouse experiments were approved by the Animal Care and Use Committee of Central South University and conducted in accordance with the official recommendations of the Care and Use of Laboratory Animals (approval no. 2021535; Changsha, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}